Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1Phase 1 1

Status

Unknown 6Completed 3

Sponsor Class

OTHER 47INDUSTRY 6OTHER_GOV 3UNKNOWN 2

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 2Sarcoma 1Lymphoid 1Gastrointestinal 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Osteosarcoma 1Lymphoma, T-Cell, Peripheral 1Esophageal Neoplasms 1Brain Neoplasms 1

Interventions

Injections 54Cisplatin 49Paclitaxel 48Carboplatin 43Gemcitabine 38pembrolizumab 36Docetaxel 36Capecitabine 36Drug Therapy 34anlotinib 25Bevacizumab 25Fluorouracil 24Cyclophosphamide 24icotinib 23Oxaliplatin 20fludarabine 19Pemetrexed 17Leucovorin 16Irinotecan 16Temozolomide 14Nivolumab 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Trastuzumab 12Rituximab 11Fulvestrant 11Etoposide 11tesetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × endostar protein × Clear all
NCT04942301 2021-06-30

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Unknown
24 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02520219 2015-08-11

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Phase 2 Unknown
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT02513355 2015-08-04

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Phase 4 Unknown
400 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01002092 2014-09-03

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

Phase 2 Unknown
160 enrolled
Sarcoma

Osteosarcoma

NCT01368419 2013-04-24

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Unknown
40 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01410370 2013-04-24

Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Unknown
80 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡